Who owns the AMORCEY trademark?

The AMORCEY trademark is owned by Bausch Health Ireland Limited.

What class is the AMORCEY trademark registered in?

The AMORCEY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for AMORCEY?

The USPTO serial number for AMORCEY is 79429968.

What is the registration number for AMORCEY?

AMORCEY is registered under USPTO registration number 8200420.

Sealvo

Home Search: AMORCEYAMORCEY #79429968

Back

Updated Oct 21, 2026·37 searches this week

View on USPTO TSDR Find similar marks

AMO

USPTO Trademark Record

REGISTERED

AMORCEY

SN 79429968·Reg 8200420·Filed Jul 11, 2025

Owner Bausch Health Ireland Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

AMORCEY (Serial No. 79429968), Registration No. 8200420, is a registered US trademark filed on Jul 11, 2025 by Bausch Health Ireland Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 07, 2032

Mark Intelligence

AMORCEY (Reg. #8200420) is a registered US trademark that has been protecting its owner, Bausch Health Ireland Limited, since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 11, 2025

SERIAL

79429968

REG#

8200420

REGISTERED

Apr 07, 2026

Filing Information

StatusREGISTERED

Filing DateJul 11, 2025

Serial Number79429968

Registration No.8200420

Registration DateApr 07, 2026

Status DateApr 07, 2026

Published for OppositionFeb 17, 2026

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Oct 01, 2026

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Sep 14, 2026

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Sep 14, 2026

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jul 07, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Apr 07, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 07, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 17, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 17, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 11, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

REFUSAL PROCESSED BY IB

Jan 29, 2026

REFUSAL PROCESSED BY IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 22, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 13, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 13, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 13, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY MPU

Jan 09, 2026

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 09, 2026

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

Dec 18, 2025

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 03, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Dec 02, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Dec 01, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 15, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Aug 15, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 14, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Bausch Health Ireland Limited

Additional USPTO filings from the same owner.

ARA

ARAZLO

88086551

BAUSCH HEALTH IRELAND LIMITED

REGISTERED

KLA

KLARTOPE

79439211

Bausch Health Ireland Limited

REGISTERED

HYD

HYDROSPAN

79444223

Bausch Health Ireland Limited

REGISTERED

ORI

ORIZMAR

79439174

Bausch Health Ireland Limited

REGISTERED

Other Marks by Jeremy Blackowicz

Additional USPTO filings handled by the same attorney of record.

LOG

LogoMark

79438645

REGISTERED

ORA

ORATALKS

99412491

REGISTERED

ARA

ARAZLO

88086551

REGISTERED

ORA

ORAPHARMA

75878686

REGISTERED

AMORCEY

Run a conflict check

Other Marks by Bausch Health Ireland Limited

Other Marks by Jeremy Blackowicz

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company